Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) - Total Assets
Based on the latest financial reports, Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) holds total assets worth CN¥1.76 Billion CNY (≈ $257.17 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Anhui Sunhere Pharmaceutical Excipients to assess how comfortably operating cash covers total debt obligations.
Anhui Sunhere Pharmaceutical Excipients Co Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Anhui Sunhere Pharmaceutical Excipients Co Ltd's total assets have evolved over time, based on quarterly financial data. See Anhui Sunhere Pharmaceutical Excipients shareholders equity for net asset value and shareholders' equity analysis.
Anhui Sunhere Pharmaceutical Excipients Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Anhui Sunhere Pharmaceutical Excipients Co Ltd's total assets of CN¥1.76 Billion consist of 67.2% current assets and 32.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.5% |
| Accounts Receivable | CN¥129.32 Million | 7.6% |
| Inventory | CN¥92.26 Million | 5.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥54.99 Million | 3.2% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Anhui Sunhere Pharmaceutical Excipients Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Anhui Sunhere Pharmaceutical Excipients .
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anhui Sunhere Pharmaceutical Excipients Co Ltd's current assets represent 67.2% of total assets in 2025, an increase from 55.4% in 2011.
- Cash Position: Cash and equivalents constituted 17.5% of total assets in 2025, down from 28.2% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 22.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 7.6% of total assets.
Anhui Sunhere Pharmaceutical Excipients Co Ltd Competitors by Total Assets
Key competitors of Anhui Sunhere Pharmaceutical Excipients Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
|
China | CN¥2.30 Billion |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
|
China | CN¥8.59 Billion |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
|
China | CN¥925.41 Million |
|
Jw Pharmac
KO:001060
|
Korea | ₩605.27 Billion |
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Samjin Pharm
KO:005500
|
Korea | ₩449.14 Billion |
Anhui Sunhere Pharmaceutical Excipients Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.39 | 4.94 | 2.34 |
| Quick Ratio | 4.06 | 4.56 | 2.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥927.97 Million | CN¥841.40 Million | CN¥270.52 Million |
Anhui Sunhere Pharmaceutical Excipients Co Ltd - Advanced Valuation Insights
This section examines the relationship between Anhui Sunhere Pharmaceutical Excipients Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.69 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 9.8% |
| Total Assets | CN¥1.71 Billion |
| Market Capitalization | $422.68 Million USD |
Valuation Analysis
Below Book Valuation: The market values Anhui Sunhere Pharmaceutical Excipients Co Ltd's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Anhui Sunhere Pharmaceutical Excipients Co Ltd's assets grew by 9.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Anhui Sunhere Pharmaceutical Excipients Co Ltd (2011–2025)
The table below shows the annual total assets of Anhui Sunhere Pharmaceutical Excipients Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.71 Billion ≈ $250.65 Million |
+9.82% |
| 2024-12-31 | CN¥1.56 Billion ≈ $228.24 Million |
+1.10% |
| 2023-12-31 | CN¥1.54 Billion ≈ $225.75 Million |
+30.68% |
| 2022-12-31 | CN¥1.18 Billion ≈ $172.75 Million |
+22.64% |
| 2021-12-31 | CN¥962.58 Million ≈ $140.86 Million |
+6.85% |
| 2020-12-31 | CN¥900.87 Million ≈ $131.83 Million |
+11.20% |
| 2019-12-31 | CN¥810.17 Million ≈ $118.55 Million |
+14.15% |
| 2018-12-31 | CN¥709.75 Million ≈ $103.86 Million |
+6.50% |
| 2017-12-31 | CN¥666.40 Million ≈ $97.52 Million |
+29.94% |
| 2016-12-31 | CN¥512.85 Million ≈ $75.05 Million |
+11.96% |
| 2015-12-31 | CN¥458.06 Million ≈ $67.03 Million |
+71.95% |
| 2014-12-31 | CN¥266.39 Million ≈ $38.98 Million |
+14.05% |
| 2013-12-31 | CN¥233.58 Million ≈ $34.18 Million |
+10.08% |
| 2012-12-31 | CN¥212.20 Million ≈ $31.05 Million |
+74.64% |
| 2011-12-31 | CN¥121.51 Million ≈ $17.78 Million |
-- |
About Anhui Sunhere Pharmaceutical Excipients Co Ltd
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. was founded in 2001 and is based in Huainan, China.